Vanguard Investments Australia
UTHR icon

Vanguard Investments Australia’s United Therapeutics UTHR Stock Holding History

Vanguard Investments Australia’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Sell
18,807
-244
-1% -$137K 0.03% 479
2026
Q1 		$11.3M Buy
+19,051
New +$9.49M 0.03% 429

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vanguard Investments Australia's UTHR Position: Q2 2026 in Review

Vanguard Investments Australia reduced its United Therapeutics (UTHR) stake by 1.3% in Q2 2026, selling an estimated $137K and leaving 18,807 shares worth $10.2M. The position accounts for 0.03% of the portfolio, ranked #479.

Vanguard Investments Australia first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.3M in Q1 2026. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Vanguard Investments Australia held 18,807 shares of United Therapeutics worth $10.2M as of Q2 2026.
  • Vanguard Investments Australia sold 244 United Therapeutics shares in Q2 2026, an estimated $137K.
  • United Therapeutics made up 0.03% of Vanguard Investments Australia's portfolio in Q2 2026, its #479 holding.
  • Vanguard Investments Australia first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's United Therapeutics position peaked at $11.3M in Q1 2026.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.